Alseres Pharmaceuticals, Inc. Announces 2008 Annual Stockholders Meeting
tropane are registeredtrademarks of Alseres Pharmaceuticals Inc. ...Sharon Correia -- 508-497-2360 ext. 224 ...Alseres Pharmaceuticals Inc. ... scorreia@alseres.com ...
Date:5/29/2008
tropane are registered
trademarks of Alseres Pharmaceuticals, Inc.
Contact:
Sharon Correia -- 508-497-2360 ext. 224
Alseres Pharmaceuticals, Inc.
scorreia@alseres.com
Adam Friedman -- 212-981-2529 ext. 18
Adam Friedman Associates
adam@adam-friedman.com
'/>"/>SOURCE Alseres Pharmaceuticals, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 Related medicine news :1.
Vista Partners Initiates Coverage on Alseres Pharmaceuticals, Inc. (Nasdaq: ALSE)2.
Alseres Pharmaceuticals, Inc. Reports First Quarter 2008 Operational and Financial Results3.
Alseres Pharmaceuticals to Host 2008 First Quarter Conference Call4.
Alseres Pharmaceuticals, Inc. to Present at The Neurotech Industry Investing & Partnering Conference5.
Alseres Pharmaceuticals, Inc. Complies With NASDAQ Rule Regarding Recently Filed 10-K6.
Alseres Pharmaceuticals, Inc. Raises $5 Million7.
Alseres Pharmaceuticals, Inc. to Present at New York Society of Security Analysts Conference8.
Lotus Pharmaceuticals, Inc. Announces Conference Call to Discuss First Quarter 2008 Results9.
Lotus Pharmaceuticals, Inc. Announces Resignation of Director Mel Rothberg10.
Aida Pharmaceuticals, Inc. Announces Availability of Downloadable Corporate Synopsis on its Website11.
Lotus Pharmaceuticals, Inc. Announces Fourth Quarter and Fiscal Year 2007 Results